Overview

Digoxin Medulloblastoma Study

Status:
RECRUITING

Trial end date:
2027-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy of digoxin in treating relapsed non-SHH, non-WNT medulloblastoma in pediatric and young adult patients.

Phase:

PHASE2

Details

Lead Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Collaborator:

National Pediatric Cancer Foundation

Treatments:

Digoxin